The Pre-metastatic Niche-related Index Reveals the ImmuneSignature and Immunotherapy Response in Lung Adenocarcinoma
We confirmed that the PMN-associated index is a valid predictor of prognosis, immune characteristics, and antitumor therapy efficacy in LUAD patients, which provides additional evidence for the potential clinical value of PMN development.
Authors
- Xiaoqun Ye (ORCID: https://orcid.org/0000-0001-9682-3789)
- Jiajia Xiang (ORCID: https://orcid.org/0000-0001-5404-0735)
- Weichang Yang (ORCID: https://orcid.org/0000-0001-6596-1791)
- Shanshan Cai (ORCID: https://orcid.org/0000-0003-0117-5171)
- Zhijian Wu
Institutions
- Nanchang University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-04-29
- DOI
- https://doi.org/10.2174/0109298673354164250414003620
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00